Icecure Medical Ltd (ICCM) Stock: A Study of the Market Performance

The stock of Icecure Medical Ltd (ICCM) has seen a 5.93% increase in the past week, with a 0.00% drop in the past month, and a 7.76% flourish in the past quarter. The volatility ratio for the week is 5.67%, and the volatility levels for the past 30 days are at 4.47% for ICCM. The simple moving average for the past 20 days is 1.61% for ICCM’s stock, with a 15.46% simple moving average for the past 200 days.

Is It Worth Investing in Icecure Medical Ltd (NASDAQ: ICCM) Right Now?

Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for ICCM is 20.05M, and currently, shorts hold a 1.21% of that float. The average trading volume for ICCM on April 04, 2024 was 566.80K shares.

ICCM) stock’s latest price update

Icecure Medical Ltd (NASDAQ: ICCM) has experienced a decline in its stock price by -6.72 compared to its previous closing price of 1.34. However, the company has seen a gain of 5.93% in its stock price over the last five trading days. Seeking Alpha reported 2024-04-03 that IceCure Medical Ltd. (NASDAQ:ICCM ) Q4 2023 Earnings Conference Call April 3, 2024 10:00 AM ET Company Participants Michael Polyviou – EVC Group, Investor Relations Eyal Shamir – Chief Executive Officer Shad Wood – VP of Sales, North American Tlalit Bussi Tel-Tzure – VP of Business Development and Global Marketing Ronen Tsimerman – Chief Financial Officer and Chief Operating Officer Conference Call Participants Kemp Dolliver – Brookline Capital Markets Yi Che – H.C.

ICCM Trading at -4.25% from the 50-Day Moving Average

After a stumble in the market that brought ICCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.38% of loss for the given period.

Volatility was left at 4.47%, however, over the last 30 days, the volatility rate increased by 5.67%, as shares sank -0.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.58% lower at present.

During the last 5 trading sessions, ICCM rose by +5.93%, which changed the moving average for the period of 200-days by +1.63% in comparison to the 20-day moving average, which settled at $1.2298. In addition, Icecure Medical Ltd saw 16.82% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for ICCM

Current profitability levels for the company are sitting at:

  • -5.52 for the present operating margin
  • 0.41 for the gross margin

The net margin for Icecure Medical Ltd stands at -5.3. The total capital return value is set at -1.06.

Based on Icecure Medical Ltd (ICCM), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -23.34. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 95.22.

Currently, EBITDA for the company is -16.49 million with net debt to EBITDA at 0.2. When we switch over and look at the enterprise to sales, we see a ratio of 18.52. The receivables turnover for the company is 2.87for trailing twelve months and the total asset turnover is 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.03.

Conclusion

In conclusion, Icecure Medical Ltd (ICCM) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts